Background Cancer registry statistics on cancer in Yemen are poor . In southeastern of Yemen the cancer cases during the P...
Upcoming SlideShare
Loading in …5

Breast Cancer In Yemen


Published on


  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Breast Cancer In Yemen

  1. 1. Background Cancer registry statistics on cancer in Yemen are poor . In southeastern of Yemen the cancer cases during the Period 1989-1993 and 1997-2001 showed that breast cancer was the first most common malignancy in Yemen in Female Aim of study 1) To determine out the pattern of breast cancer in Yemeni patients in limited resource centre 2) To compare the results with those from other parts of the world 3) To expose the obstacles and difficulties faced doctors in diagnosis and treatment Materials and methods Retrospective study, conducted in Al-Amal Oncology Unit, Al-Gamhoria Teaching Hospital during the period from January 2008 to December 2008. The analyzed data included all patients admitted to ALAMAL oncology unit. The data included in this study were patients sex, age, affected site, histopathological diagnosis, metastasis and outcome. <ul><li>Results </li></ul><ul><li>Patients with breast cancer were 110 registered during one year (2008). </li></ul><ul><li>The patients registered were 110 patients. 109 patients were female (99.1%) and one male. </li></ul><ul><li>In 87.3% of patients there is evidence of metastasis </li></ul><ul><li>The age group most affected was 40-49 years followed by age group 50-59 years and 30-39 years. 5 patients were in the age group of 20-29 years </li></ul><ul><li>The age group involved is younger than in Europe and the USA. The most common group involved was 4th decade (33.6%), followed by the 5th decade (25.5%) and 3rd decade (21.8%). </li></ul><ul><li>) </li></ul>Conclusions The study has several limitations and observations that must be taken into account: First, Absence of mammography and other early diagnostic procedures played a role for late diagnosis of breast cancer. The sad truth is that we have to consider all women older than 30 at risk for this disease. Also we appear to have a particularly steep rise of the disease in women younger than 50. The situation in Yemen is compounded by the fact that the presentation is often late and high rate of metastasis is observed in our patients The national Cancer committee together with other groups such as hospitals of the Ministry of Health, WHO, Yemen Women Centre, The International Cancer Associations, are to advocate for increasing funds for research, both basis , applied and for increased support for early detection of breast and cervical carcinoma. This collaborative advocacy brings focus on the government to address problems caused by cancer and will foster effective action. What remains clear is that there is an urgent need for a comprehensive national approach to tackle this issue Gamal Abdul Hamid 1 , Nadeem M Saeed 2 , Reem Bader Amin 1 , Safa Shukry 1 Al-Amal oncology unit, Aden, National oncology centre, Sana'a, Yemen <ul><li>Recommendations </li></ul><ul><li>Improvement quality of laboratory and nuclear medicine. </li></ul><ul><li>2. Urgent need for establishment nuclear medicine and radiotherapy centers </li></ul><ul><li>3. Urgent need for establishment early detection programs </li></ul><ul><li>Contact: </li></ul><ul><li>Associate Prof. Dr Gamal Abdul Hamid </li></ul><ul><li>Head, Hematology-Oncology, </li></ul><ul><li>Al-Gamhouria teaching Hospital </li></ul><ul><li>[email_address] </li></ul>The results show that most of the patients (76.1%) had infiltrating ductal carcinoma Out of this breast cancer were 57.3% on the right breast and 39.1% on the left breast. And 3.6 were bilateral. The absence of carcinoma in situ reflects the late diagnosis of breast cancer in contrast to Europe and the USA due to developed programs early detection of breast cancer Distribution of breast cancer types Breast Cancer in limited resource centre <ul><li>1. About 75.5% of the patients were with lymph node involvement. </li></ul><ul><li>2. About 10.0% are bone, 7.3% lung metastasis , 0.9% ovary metastasis , and 12.7% are free of metastasis </li></ul><ul><li>Prognosis: </li></ul>